PRL and neoplasm: This phenomenon was also described by Vroonen et al. (12) where patients who did not respond to cabergoline had a 50% decrease in the dose of the drug, achieved normalization of prolactin concentrations in 33% of the cases, and showed complete reduction in tumor mass in 36.8% of the cases after surgery.